On May 16, GLONGHUI (301333.SZ) said on an interactive platform that the company's business in the US is mainly data management and statistical analysis services, and that at this stage, the biological law has no impact on the company's business in the US.
诺思格(301333.SZ)：现阶段生物法案对公司在美国的业务没有影响
Norske (301333.SZ): At this stage, the Biological Act has no impact on the company's business in the US
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.